Okumoto K, Bogaki A, Tateishi K, Tsukamoto T, Osumi T, Shimozawa N, Suzuki Y, Orii T, Fujiki Y
Department of Biology, Kyushu University Faculty of Science, Fukuoka, Japan.
Exp Cell Res. 1997 May 25;233(1):11-20. doi: 10.1006/excr.1997.3552.
We made use of the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method and isolated peroxisome-deficient mutant cells. TKa cells, the wild-type Chinese hamster ovary (CHO) cells, CHO-K1, that had been stably transfected with cDNA encoding Pex2p (formerly peroxisome assembly factor-1, PAF-1) were used to avoid frequent isolation of the Z65-type, PEX2-defective mutants. P9OH/UV-resistant cell colonies were examined for the intracellular location of catalase, a peroxisomal matrix enzyme, by immunofluorescence microscopy and using anti-catalase antibody. As six mutant cell clones showed cytosolic catalase, there was likely to be a deficiency in peroxisome assembly. These mutants also showed the typical peroxisome assembly-defective phenotype, including significant decrease of dihydroxyacetonephosphate acyltransferase, the first step key enzyme in plasmalogen synthesis, and loss of resistance to 12-(1'-pyrene)dodecanoic acid/UV treatment. By transfection of Pex2p and Pex6p (formerly PAF-2) cDNAs and cell fusion analysis between the CHO cell mutants, two mutants, ZP104 and ZP109, were found to belong to a novel complementation group. Further complementation analysis using fibroblasts from patients with peroxisome biogenesis disorders revealed that the mutants belonged to human complementation group III. Taken together, ZP104 and ZP109 are in a newly identified fifth complementation group in CHO mutants reported to date and represent the human complementation group III.
我们采用9-(1'-芘基)壬醇/紫外线(P9OH/UV)方法分离出了过氧化物酶体缺陷型突变细胞。为避免频繁分离出Z65型、PEX2缺陷型突变体,我们使用了已稳定转染编码Pex2p(以前称为过氧化物酶体组装因子-1,PAF-1)的cDNA的野生型中国仓鼠卵巢(CHO)细胞TKa细胞和CHO-K1细胞。通过免疫荧光显微镜并使用抗过氧化氢酶抗体,对P9OH/UV抗性细胞集落进行了过氧化氢酶(一种过氧化物酶体基质酶)的细胞内定位检查。由于六个突变细胞克隆显示出胞质过氧化氢酶,因此过氧化物酶体组装可能存在缺陷。这些突变体还表现出典型的过氧化物酶体组装缺陷表型,包括磷酸二羟丙酮酰基转移酶(缩醛磷脂合成中的第一步关键酶)显著减少,以及对12-(1'-芘基)十二烷酸/紫外线处理的抗性丧失。通过转染Pex2p和Pex6p(以前称为PAF-2)的cDNA以及CHO细胞突变体之间的细胞融合分析,发现两个突变体ZP104和ZP109属于一个新的互补群。使用过氧化物酶体生物发生障碍患者的成纤维细胞进行的进一步互补分析表明,这些突变体属于人类互补群III。综上所述,ZP104和ZP109属于迄今为止报道的CHO突变体中一个新鉴定的第五互补群,代表人类互补群III。